{
  "path": "_news",
  "content": "<div class='row'><div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.cnbc.com/2020/03/27/who-officials-enroll-first-patients-from-norway-and-spain-in-historic-coronavirus-drug-trial.html\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fimage.cnbcfm.com%2Fapi%2Fv1%2Fimage%2F106454187-1584724017641gettyimages-1204797411.jpeg%3Fv%3D1584724086&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.cnbc.com/2020/03/27/who-officials-enroll-first-patients-from-norway-and-spain-in-historic-coronavirus-drug-trial.html\">WHO officials enroll first patients from Norway and Spain in 'historic' coronavirus drug trial</a></div>\r\n\t\t<div class=\"card-excerpt\">World Health Organization officials are holding a press conference Friday to update the public on the coronavirus outbreak.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">CNBC</span> • <span class=\"card-date\">3/27/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.washingtonpost.com/health/2020/03/27/coronavirus-serum-plasma-treatment/\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.washingtonpost.com%2Fresizer%2F4ny46TGs-2rr-kclJi5lHEDBpZw%3D%2F1440x0%2Fsmart%2Farc-anglerfish-washpost-prod-washpost.s3.amazonaws.com%2Fpublic%2FOFGO6LDOCII6VIKWABELMLG3KE.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.washingtonpost.com/health/2020/03/27/coronavirus-serum-plasma-treatment/\">Blood from people who recover from coronavirus could provide a treatment</a></div>\r\n\t\t<div class=\"card-excerpt\">People who recover from the coronavirus could play an essential role in fighting the disease -- by donating plasma that could help others fight off infection.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Washington Post</span> • <span class=\"card-date\">3/27/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.usatoday.com/story/news/factcheck/2020/03/27/fact-check-coronavirus-gilead-sciences-received-withdrew-fda-orphan-status-remdesivir/2922115001/\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.gannett-cdn.com%2Fpresto%2F2020%2F03%2F27%2FUSAT%2F33caaba9-298d-4454-856d-f87f0c6c2a36-AFP_AFP_1Q78FJ.JPG%3Fauto%3Dwebp%26crop%3D5313%2C2989%2Cx0%2Cy353%26format%3Dpjpg%26width%3D1200&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.usatoday.com/story/news/factcheck/2020/03/27/fact-check-coronavirus-gilead-sciences-received-withdrew-fda-orphan-status-remdesivir/2922115001/\">Fact check: Drugmaker Gilead Sciences claimed rights to a possible COVID-19 treatment</a></div>\r\n\t\t<div class=\"card-excerpt\">Gilead Sciences received special FDA protection for the antiviral drug remdesivir. Facing criticism, it withdrew its request for \"orphan status.\"</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">USA Today</span> • <span class=\"card-date\">3/27/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.cnbc.com/2020/03/27/coronavirus-vaccine-novartis-ceo-says-its-too-soon-to-know-whether-malaria-drugs-can-work.html\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fimage.cnbcfm.com%2Fapi%2Fv1%2Fimage%2F105932498-1558717769811gettyimages-1088275184.jpeg%3Fv%3D1584735079&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.cnbc.com/2020/03/27/coronavirus-vaccine-novartis-ceo-says-its-too-soon-to-know-whether-malaria-drugs-can-work.html\">Swiss pharma giant says it's 'too soon' to know whether malaria drug could be coronavirus treatment</a></div>\r\n\t\t<div class=\"card-excerpt\">The CEO of Novartis said it is \"too soon\" to know whether two anti-malaria drugs could be the definitive treatment for the coronavirus.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">CNBC</span> • <span class=\"card-date\">3/27/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.washingtonpost.com/health/people-in-addiction-treatment-are-losing-crucial-support-during-coronavirus-pandemic/2020/03/26/5698eae0-6ac6-11ea-abef-020f086a3fab_story.html\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.washingtonpost.com%2Fresizer%2FTzNGkOr_E4NtY6vYc3QgOX5RqzE%3D%2F1440x0%2Fsmart%2Farc-anglerfish-washpost-prod-washpost.s3.amazonaws.com%2Fpublic%2FUV53VVTO4MI6VIKWABELMLG3KE.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.washingtonpost.com/health/people-in-addiction-treatment-are-losing-crucial-support-during-coronavirus-pandemic/2020/03/26/5698eae0-6ac6-11ea-abef-020f086a3fab_story.html\">People in addiction treatment are losing crucial support during coronavirus pandemic</a></div>\r\n\t\t<div class=\"card-excerpt\">It’s why, until recently, he was showing up three days a week in suburban Maryland, leading group support sessions before heading to his midnight shift as a project manager for Metro. “Isolation is a luxury that you have to learn to grow into,</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Washington Post</span> • <span class=\"card-date\">3/27/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.washingtonpost.com/local/education/teens-are-discovering-a-cure-for-coronavirus-anxiety-walks-no-phones-allowed/2020/03/26/ca2e36ba-6c40-11ea-aa80-c2470c6b2034_story.html\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.washingtonpost.com%2Fresizer%2Fh6ZYna48ZWxXELpXyeLppAogOCo%3D%2F1440x0%2Fsmart%2Farc-anglerfish-washpost-prod-washpost.s3.amazonaws.com%2Fpublic%2FHXYU7BTO4EI6VIKWABELMLG3KE.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.washingtonpost.com/local/education/teens-are-discovering-a-cure-for-coronavirus-anxiety-walks-no-phones-allowed/2020/03/26/ca2e36ba-6c40-11ea-aa80-c2470c6b2034_story.html\">Teens are discovering a cure for coronavirus anxiety: Walks. No phones allowed.</a></div>\r\n\t\t<div class=\"card-excerpt\">For a half-hour or so, she walks. She chooses random directions at the four-way intersections that dot her neighborhood. She stops to feel the spring sunlight on her skin. She leans in, close, to look at dandelions.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Washington Post</span> • <span class=\"card-date\">3/27/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.axios.com/remdesivir-orphan-designation-coronavirus-f5aaedcf-f2b8-4874-89ab-433e2561b60e.html\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fimages.axios.com%2Fz8KiAp7mXrvHDYeEm2C6yCJ7XCM%3D%2F2020%2F03%2F27%2F1585305124428.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.axios.com/remdesivir-orphan-designation-coronavirus-f5aaedcf-f2b8-4874-89ab-433e2561b60e.html\">Experimental coronavirus treatment's surprising \"orphan\" designation</a></div>\r\n\t\t<div class=\"card-excerpt\">Background: Pharmaceutical company Gilead Sciences is running clinical trials to test whether one of its drugs, called remdesivir, is an effective treatment against the novel coronavirus. On Monday, the FDA granted remdesivir status as an \"orphan\" drug. Orphan status is reserved for drugs that treat rare diseases. It gives their developers ...</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Axios</span> • <span class=\"card-date\">3/27/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.ibtimes.com/coronavirus-treatment-israel-use-unapproved-drug-treat-covid-19-2947804\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fs1.ibtimes.com%2Fsites%2Fwww.ibtimes.com%2Ffiles%2Fstyles%2Ffull%2Fpublic%2F2020%2F03%2F19%2Fa-fransiscan-friar-stops-in-front-of-closed.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.ibtimes.com/coronavirus-treatment-israel-use-unapproved-drug-treat-covid-19-2947804\">Coronavirus Treatment: Israel To Use Unapproved Drug To Treat COVID-19</a></div>\r\n\t\t<div class=\"card-excerpt\">The unapproved drug is a mix of lopinavir and ritonavir and is manufactured by American biopharmaceutical firm AbbVie.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">International Business Times</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.ibtimes.com/coronavirus-treatment-hiv-drug-used-cure-covid-19-positive-british-national-india-2947136\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fs1.ibtimes.com%2Fsites%2Fwww.ibtimes.com%2Ffiles%2Fstyles%2Ffull%2Fpublic%2F2017%2F02%2F02%2Fresearchers-receive-25-million-funding-test-combined-hiv-drugs-patients.png&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.ibtimes.com/coronavirus-treatment-hiv-drug-used-cure-covid-19-positive-british-national-india-2947136\">Coronavirus Treatment: HIV Drug Used To Cure COVID-19 Positive British National In India</a></div>\r\n\t\t<div class=\"card-excerpt\">As the world battles the coronavirus pandemic, doctors throughout the world have been experimenting with several drugs to treat coronavirus patients. Doctors in Kerala, India have begun using anti-HIV medicines on COVID-19 patients.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">International Business Times</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.cbc.ca/news/health/coronavirus-treatment-and-vaccine-development-1.5511346\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fi.cbc.ca%2F1.5509820.1585164070%21%2FfileImage%2FhttpImage%2Fimage.JPG_gen%2Fderivatives%2F16x9_620%2Fhealth-coronavirus-usa.JPG&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.cbc.ca/news/health/coronavirus-treatment-and-vaccine-development-1.5511346\">Coronavirus: The latest in drug treatment and vaccine development</a></div>\r\n\t\t<div class=\"card-excerpt\">This undated transmission electron microscope image shows the novel coronavirus, the virus that causes COVID ... Here are the latest developments in the research. March 26: University of Manitoba researchers begin recruiting participants for a series of trials to test whether the malaria drug hydroxychloroquine can reduce the symptoms and ...</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">CBC.ca</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.cnet.com/how-to/coronavirus-vaccines-the-drugs-in-development-to-treat-covid-19/\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fcnet4.cbsistatic.com%2Fimg%2FbFGoWxsdS_r19mxEEKF4_d6wQig%3D%2F0x0%3A1225x1089%2F756x567%2F2020%2F03%2F14%2F8b6352f3-8a43-4b7c-86de-5a105ff52d29%2Fgettyimages-144560269.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.cnet.com/how-to/coronavirus-vaccines-the-drugs-in-development-to-treat-covid-19/\">Coronavirus vaccines: The drugs in development to treat COVID-19</a></div>\r\n\t\t<div class=\"card-excerpt\">Researchers are racing to develop new treatments and therapies to tackle the coronavirus pandemic. Here's what you need to know about them.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">CNET</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.rawstory.com/2020/03/coronavirus-a-new-type-of-vaccine-using-rna-could-help-defeat-covid-19/\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.rawstory.com%2Fwp-content%2Fuploads%2F2020%2F03%2FThis-scanning-electron-microscope-image-shows-SARS-CoV-2-round-blue-objects-emerging-from-the-surface-of-cells-cultured-in-the-lab.-NIAID-RML.jpeg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.rawstory.com/2020/03/coronavirus-a-new-type-of-vaccine-using-rna-could-help-defeat-covid-19/\">Coronavirus: a new type of vaccine using RNA could help defeat COVID-19</a></div>\r\n\t\t<div class=\"card-excerpt\">SARS-CoV-2, like other coronaviruses, is named for the crown-like spikes on its surface ... An mRNA vaccine for COVID-19 to undergo trial Using this strategy, biotechnology firm Moderna Inc. announced on Feb. 24 that it had rapidly developed an experimental COVID-19 mRNA vaccine called mRNA-1273, ready for clinical trials in humans.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">The Raw Story</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.propublica.org/article/republican-billionaire-group-pushes-unproven-covid-19-treatment-trump-promoted\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fassets.propublica.org%2Fimages%2Farticles%2F20200326-covid-treatment-billionaire-1200x630.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.propublica.org/article/republican-billionaire-group-pushes-unproven-covid-19-treatment-trump-promoted\">Republican Billionaire’s Group Pushes Unproven COVID-19 Treatment Trump Promoted</a></div>\r\n\t\t<div class=\"card-excerpt\">A conservative business group founded by a prolific Republican political donor is pressuring the White House to greenlight an unproven COVID-19 treatment, saying in an online petition that the country has plants in the U.S. ready to produce a drug but can’t because of “red tape, regulation, and a dysfunctional healthcare supply chain.”</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">ProPublica</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.reuters.com/article/us-health-coronavirus-regeneron-pharms-s-idUSKBN2131TP\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fs4.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20200316%26t%3D2%26i%3D1503946701%26w%3D%26fh%3D545px%26fw%3D%26ll%3D%26pl%3D%26sq%3D%26r%3DLYNXMPEG2F17R&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.reuters.com/article/us-health-coronavirus-regeneron-pharms-s-idUSKBN2131TP\">Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment</a></div>\r\n\t\t<div class=\"card-excerpt\">Sanofi SA and partner Regeneron Pharmaceuticals Inc have started a clinical trial of their rheumatoid arthritis drug Kevzara as a treatment for the coronavirus, the companies said on Monday. Enrolments for the mid-to-late stage trial will begin immediately,</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Reuters</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://time.com/5809955/blood-plasma-coronavirus/\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Finsideout.app%2Fcoronavirus%2Fassets%2Fimages%2Ftopics%2Ftreatment.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://time.com/5809955/blood-plasma-coronavirus/\">Blood Plasma Treatment For Coronavirus Set to Get Its First Trial Run in New York</a></div>\r\n\t\t<div class=\"card-excerpt\">The New York Blood Center (NYBC) is the first blood-gathering organization in the U.S. to collect plasma from COVID-19 patients to use as a possible treatment for the disease. Before antibiotics rendered the practice moot, it was common to treat infectious bacterial diseases by infusing the blood of recovered patients into those struggling with ...</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Time</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.fool.com/investing/2020/03/26/better-coronavirus-stock-gilead-sciences-vs-modern.aspx\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fg.foolcdn.com%2Fimage%2F%3Furl%3Dhttps%253A%252F%252Fg.foolcdn.com%252Feditorial%252Fimages%252F565062%252Fcovid-19-coronavirus-wood-blocks.jpg%26w%3D1200%26op%3Dresize&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.fool.com/investing/2020/03/26/better-coronavirus-stock-gilead-sciences-vs-modern.aspx\">Better Coronavirus Stock: Gilead Sciences vs. Moderna</a></div>\r\n\t\t<div class=\"card-excerpt\">Follow @keithspeights Quite a few drugmakers are racing to develop antiviral therapies to combat novel coronavirus disease COVID-19 and vaccines to immunize against infection from the virus. Two of the clear leaders on both of these fronts are Gilead Sciences (NASDAQ:GILD) and Moderna (NASDAQ:MRNA). Both stocks have performed relatively well ...</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">The Motley Fool</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.washingtonpost.com/nation/2020/03/26/fake-coronavirus-cure-fraud/\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.washingtonpost.com%2Fresizer%2FwOX_a0TGMAsDnz_xI6zv5gGbukA%3D%2F1440x0%2Fsmart%2Farc-anglerfish-washpost-prod-washpost.s3.amazonaws.com%2Fpublic%2F4JMVWUIU4ZFCBJDHPSB75C7QZU.png&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.washingtonpost.com/nation/2020/03/26/fake-coronavirus-cure-fraud/\">Small-time actor peddled fake coronavirus cure to millions online, feds charge in first covid-19 prosecution</a></div>\r\n\t\t<div class=\"card-excerpt\">The Justice Department brought its first coronavirus-related criminal fraud case in the nation on Wednesday night, accusing a small-time actor in Southern California of peddling a fake cure to millions of his and trying to woo investors with promises of millions of dollars in returns.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Washington Post</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://in.reuters.com/article/health-coronavirus-gilead-sciences-idINL4N2BI4NV\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fs4.reutersmedia.net%2Fresources_v3%2Fimages%2Frcom-default.png&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://in.reuters.com/article/health-coronavirus-gilead-sciences-idINL4N2BI4NV\">Gilead asks FDA to revoke orphan drug status for potential coronavirus drug</a></div>\r\n\t\t<div class=\"card-excerpt\">Gilead Sciences Inc said on Wednesday it had requested the U.S. Food and Drug administration to rescind the “orphan drug” status for its experimental drug, remdesivir, seen as one of the more promising potential treatments for the coronavirus.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Reuters</span> • <span class=\"card-date\">3/26/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.foxnews.com/us/connecticut-company-biosig-acquires-rights-to-potential-coronavirus-cure-report\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fcf-images.us-east-1.prod.boltdns.net%2Fv1%2Fstatic%2F694940094001%2F096e396e-0212-401d-899d-3e1eb30d3d3c%2F33b33136-d6d9-4225-a51b-8d710304f74f%2F1280x720%2Fmatch%2Fimage.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.foxnews.com/us/connecticut-company-biosig-acquires-rights-to-potential-coronavirus-cure-report\">Connecticut company BioSig acquires rights to potential coronavirus cure: report</a></div>\r\n\t\t<div class=\"card-excerpt\">A Connecticut maker of computers used by heart surgeons says one of its subsidiaries has acquired the rights to an antiviral product that is said to have potential as a coronavirus treatment. BioSig Technologies of Westport said in a statement that its NeuroClear Technoligies unit has acquired the rights to Vicromax,</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Fox News</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.ibtimes.com/coronavirus-treatment-china-touts-bear-bile-covid-19-cure-2946942\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fs1.ibtimes.com%2Fsites%2Fwww.ibtimes.com%2Ffiles%2Fstyles%2Ffull%2Fpublic%2F2017%2F11%2F28%2Fhimalayan-brown-bear.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.ibtimes.com/coronavirus-treatment-china-touts-bear-bile-covid-19-cure-2946942\">Coronavirus Treatment: China Touts Bear Bile As COVID-19 Cure</a></div>\r\n\t\t<div class=\"card-excerpt\">The Europeans recently announced a successful operation to remove fake COVID-19 medicines from markets worldwide Traditional Chinese medicine believes bear bile can cure COVID-19 The internet is flooded with fake products and fake cures for COVID-19.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">International Business Times</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.fool.com/investing/2020/03/25/gilead-asks-the-fda-to-rescind-orphan-drug-designa.aspx\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fg.foolcdn.com%2Fimage%2F%3Furl%3Dhttps%253A%252F%252Fg.foolcdn.com%252Feditorial%252Fimages%252F565264%252Fcoronavirus-patient-2.jpg%26w%3D1200%26op%3Dresize&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.fool.com/investing/2020/03/25/gilead-asks-the-fda-to-rescind-orphan-drug-designa.aspx\">Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19</a></div>\r\n\t\t<div class=\"card-excerpt\">Follow @BiologyFool Gilead Sciences (NASDAQ:GILD) has asked the Food and Drug Administration to rescind the orphan drug designation it was awarded for remdesivir as a treatment for COVID-19, the disease caused by the new coronavirus. On Monday, Gilead got some backlash on Twitter for announcing the orphan drug designation, because the ...</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">The Motley Fool</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.foxnews.com/media/dr-ben-carson-plasma-transfusion-coronavirus-treatment\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fa57.foxnews.com%2Fcf-images.us-east-1.prod.boltdns.net%2Fv1%2Fstatic%2F694940094001%2Fb170bb0a-63f6-4e33-9cdb-af59c7461952%2F8269961c-47aa-468f-a98c-85d5649ef266%2F1280x720%2Fmatch%2F931%2F524%2Fimage.jpg%3Fve%3D1%26tl%3D1&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.foxnews.com/media/dr-ben-carson-plasma-transfusion-coronavirus-treatment\">Dr. Ben Carson: Plasma transfusion coronavirus treatment being tested by New York looks 'promising'</a></div>\r\n\t\t<div class=\"card-excerpt\">Housing and Urban Development Secretary Ben Carson told \"The Story\" Wednesday that there is promise in a new therapy to fight the coronavirus contagion.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Fox News</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.axios.com/coronavirus-treatment-vaccine-research-pharma-drugs-55a28ea3-ee91-4f77-a093-44d450470b25.html\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fimages.axios.com%2FgZVVSLyhFLOtk_BjqYIUE7MI_7I%3D%2F2020%2F03%2F24%2F1585087556381.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.axios.com/coronavirus-treatment-vaccine-research-pharma-drugs-55a28ea3-ee91-4f77-a093-44d450470b25.html\">Drug companies ramp up research for a coronavirus treatment or vaccine</a></div>\r\n\t\t<div class=\"card-excerpt\">But some experimental treatments, while they still require more research, are showing promise ... patients suffering from the novel coronavirus, according to a senior Health and Human Services official and another source with direct knowledge. Why it matters: It doesn't hurt to have a potential treatment on hand, but we're still a very long ...</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Axios</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://thehill.com/policy/international/489559-india-bans-export-of-drug-touted-by-trump-as-potential-coronavirus\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fthehill.com%2Fsites%2Fdefault%2Ffiles%2Fhydroxychloroquine_032520getty.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://thehill.com/policy/international/489559-india-bans-export-of-drug-touted-by-trump-as-potential-coronavirus\">India bans export of drug touted by Trump as potential coronavirus treatment</a></div>\r\n\t\t<div class=\"card-excerpt\">India has banned the export of a malaria drug touted by President Trump as a \"game changer\" in the fight against the coronavirus pandemic.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">The Hill</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.wsj.com/articles/balancing-covid-19-with-a-destructive-cure-11585158209\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fimages.wsj.net%2Fim-166916%2Fsocial&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.wsj.com/articles/balancing-covid-19-with-a-destructive-cure-11585158209\">Balancing Covid-19 With a Destructive Cure</a></div>\r\n\t\t<div class=\"card-excerpt\">As someone who is statistically at high risk for Covid-19, I am indescribably grateful to my fellow citizens for the heroic sacrifices they are making to keep me safe. But I don’t think trashing the economy is the long-term answer for anybody.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Wall Street Journal</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.nasdaq.com/articles/gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.nasdaq.com%2Fsites%2Facquia.prod%2Ffiles%2F2019-05%2F0902-Q19%2520Total%2520Markets%2520photos%2520and%2520gif_CC8.jpg%3F2015036400&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.nasdaq.com/articles/gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for\">Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19</a></div>\r\n\t\t<div class=\"card-excerpt\">Gilead Sciences (NASDAQ: GILD) has asked the Food and Drug Administration to rescind the orphan drug designation it was awarded for remdesivir as a treatment for COVID-19, the disease caused by the new coronavirus.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Nasdaq</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.foxnews.com/entertainment/cardi-b-slams-government-coronavirus-celebs-special-treatment\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fa57.foxnews.com%2Fstatic.foxnews.com%2Ffoxnews.com%2Fcontent%2Fuploads%2F2020%2F03%2F640%2F320%2FGettyImages-1027412730.jpg%3Fve%3D1%26tl%3D1&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.foxnews.com/entertainment/cardi-b-slams-government-coronavirus-celebs-special-treatment\">Cardi B criticizes government over coronavirus response, calls out celebs getting special treatment</a></div>\r\n\t\t<div class=\"card-excerpt\">Cardi B is sounding off on the developments surrounding the coronavirus, and issued a message for the government, as well as celebrities she believes are “causing confusion” for the general public by announcing that they’ve tested positive for the novel virus,</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Fox News</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.nytimes.com/2020/03/25/world/coronavirus-news-live.html\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fwww.nytimes.com%2Fnewsgraphics%2F2020%2F03%2F04%2Fcorona-virus-social-images%2Fassets%2Fpromo.jpg%3Fu%3D1585174628581&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.nytimes.com/2020/03/25/world/coronavirus-news-live.html\">Coronavirus Live Updates: Debate Over Jobless Benefits Stalls Senate Vote on $2 Trillion Aid Package</a></div>\r\n\t\t<div class=\"card-excerpt\">Four Republican senators said the generous unemployment provisions in the bill could incentivize layoffs and discourage employees from seeking new jobs. Senate leaders still hoped to vote on the measure later Wednesday.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">New York Times</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.marketwatch.com/story/drugmaker-gilead-backpedals-on-specialty-status-for-covid-19-drug-2020-03-25\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Fs.marketwatch.com%2Fpublic%2Fresources%2Fimages%2FMW-HN288_gilead_ZH_20190714170014.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.marketwatch.com/story/drugmaker-gilead-backpedals-on-specialty-status-for-covid-19-drug-2020-03-25\">Drugmaker Gilead backpedals on specialty status for COVID-19 drug</a></div>\r\n\t\t<div class=\"card-excerpt\">WASHINGTON — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment.</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">MarketWatch</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n<div class=\"col-md-4 col-sm-12\">\r\n  <div class=\"content-card\">\r\n\t<a href=\"https://www.nasdaq.com/articles/gilead-asks-fda-to-revoke-orphan-drug-status-for-potential-coronavirus-drug-2020-03-25\"><div class=\"card-image\" style=\"background-image: url(https://images1-focus-opensocial.googleusercontent.com/gadgets/proxy?url=https%3A%2F%2Finsideout.app%2Fcoronavirus%2Fassets%2Fimages%2Ftopics%2Ftreatment.jpg&container=focus&resize_w=300&refresh=18000)\"></div></a>\r\n\t<div class=\"content\">\r\n\t\t<div class=\"card-title\"><a href=\"https://www.nasdaq.com/articles/gilead-asks-fda-to-revoke-orphan-drug-status-for-potential-coronavirus-drug-2020-03-25\">Gilead asks FDA to revoke orphan drug status for potential coronavirus drug</a></div>\r\n\t\t<div class=\"card-excerpt\">Gilead Sciences Inc said on Wednesday it had requested the U.S. Food and Drug Administration to rescind the \"orphan drug\" status for its experimental drug, remdesivir, seen as one of the more promising potential treatments for coronavirus,</div>\r\n\t\t<div class=\"card-meta\">\r\n\t\t\t<span class=\"card-provider\">Nasdaq</span> • <span class=\"card-date\">3/25/2020</span>\r\n\t\t</div>\r\n\t</div>\r\n  </div>\r\n</div>\r\n</div>"
}